Get the latest delivered to your inbox
Privacy Policy

Healthcare Services

News and content about corporate responsibility innovations in the healthcare services industry.

    Quest Diagnostics Named a ‘Best Place To Work for Disability Inclusion’ for Sixth Consecutive Year Image

    POSTED 

    07-18-23

    Quest Diagnostics Named a ‘Best Place To Work for Disability Inclusion’ for Sixth Consecutive Year

    Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2023 Disability Equality Index® (DEI) Best Places to Work for Disability Inclusion by Disability: IN.
    Quest Diagnostics Employees Support Healthy NewsWorks Student Journalists Image

    POSTED 

    07-14-23

    Quest Diagnostics Employees Support Healthy NewsWorks Student Journalists

    On May 23, several Quest Diagnostics employees volunteered at the Healthy NewsWorks Spring Celebration, featuring achievements of its student reporters from the greater Philadelphia area.
    Organon Publishes 2022 ESG Report Showcasing Progress Toward Global Sustainability Goals Image

    POSTED 

    06-29-23

    Organon Publishes 2022 ESG Report Showcasing Progress Toward Global Sustainability Goals

    Organon (NYSE: OGN), a global healthcare company focused on women’s health, today released its 2022-2023 Environmental, Social, and Governance (ESG) Report.
    Recipe for Bonding: Paid Leave Gives New Dad Needed Time Image

    POSTED 

    06-21-23

    Recipe for Bonding: Paid Leave Gives New Dad Needed Time

    “We want to support employees at every career and life stage,” said Vice President of Global Benefits and Payroll Denise King.
    Everstream Analytics & Medtronic Recognized by Supply & Demand Chain Executive Image

    POSTED 

    06-16-23

    Everstream Analytics & Medtronic Recognized by Supply & Demand Chain Executive

    The award recognizes Everstream’s UFLPA Risk Solution created to help companies uncover risk and demonstrate compliance with current and emerging forced labor requirements such as the Uyghur Forced Labor Prevention Act (UFLPA).
    Q4HE Teams Up With Experience Camps To Help Children Work Through Grief Image

    POSTED 

    06-16-23

    Q4HE Teams Up With Experience Camps To Help Children Work Through Grief

    To commemorate Mental Health Awareness Month, Quest Diagnostics Foundation grantee Experience Camps hosted several events for young people working through grief.
    Seleni Institute Announces Six New Advisory Board Members  Image

    POSTED 

    06-13-23

    Seleni Institute Announces Six New Advisory Board Members

    Seleni Institute adds six new advisory board members as the organization expands its training portfolio and impact globally. The board supports Seleni's mission to raise greater awareness around treating perinatal and reproductive mental health issues worldwide.
    Quest Diagnostics Elects Luis A. Diaz, Jr., M.D. to Its Board, Expanding the Number of Directors to 10 Image

    POSTED 

    06-12-23

    Quest Diagnostics Elects Luis A. Diaz, Jr., M.D. to Its Board, Expanding the Number of Directors to 10

    Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Luis A. Diaz, Jr., M.D. to serve as a director.  Including Dr. Diaz, the company's Board has 10 members.
    Quest’s Chicagoland Laboratory Hosts Americares Leaders During Lab Week Image

    POSTED 

    05-24-23

    Quest’s Chicagoland Laboratory Hosts Americares Leaders During Lab Week

    Quest Diagnostics is proud to support Americares in their efforts to improve health for people affected by poverty or disaster with a grant from Quest for Health Equity (Q4HE).
    Ultragenyx Issues 2022 ESG Report, Continuing To Enhance Its Leadership on Corporate Responsibility Image

    POSTED 

    05-24-23

    Ultragenyx Issues 2022 ESG Report, Continuing To Enhance Its Leadership on Corporate Responsibility

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultrarare diseases, today released its second annual ESG report.

    Join today and get the latest delivered to your inbox